JEFFREY M. ISNER
Medical Practice in Boston, MA
License number
DC MD10261
Issued Date
Aug 16, 1977
Expiration Date
Dec 31, 1998
Category
MEDICINE
Type
MEDICINE AND SURGERY
Address
Address
Ccp4Cv, Boston, MA 02135
Personal information
See more information about JEFFREY M. ISNER at radaris.comName
Address
Phone
128 Shore Dr W, Mashpee, MA 02649
34 Brenton Rd, Weston, MA 02493
34 Brenton Rd, Weston, MA 02493
560 North Ave, Weston, MA 02493
59 Summer St, Weston, MA 02493
Professional information
Catheter
US Patent:
5104393, Apr 14, 1992
Filed:
Nov 2, 1990
Appl. No.:
7/608281
Inventors:
Jeffrey M. Isner - Boston MA
Richard Clarke - Boston MA
Richard Clarke - Boston MA
Assignee:
AngeLase, Inc. - Plymouth MN
International Classification:
A61B 1736
US Classification:
606 15
Abstract:
A technique for the treatment of ventricular tachycardia. The ventricles are endocardially mapped by way of an electrophysiological workup. This mapping locates the tachycardial foci and other abnormalities in conduction. A special catheter containing an optical fiber is percutaneously inserted into a blood vessel and advanced into the ventricle. The distal tip of the catheter is positioned adjacent to each of the tachycardia generating sites. A medical laser is used to irradiate each site via the optical fiber. The tissue at each site is thereby photocoagulated or ablated to remove the source of the tachyarythmia.
Catheter
US Patent:
4985028, Jan 15, 1991
Filed:
Aug 30, 1989
Appl. No.:
7/400701
Inventors:
Jeffrey M. Isner - Boston MA
Richard Clarke - Boston MA
Richard Clarke - Boston MA
Assignee:
Angeion Corporation - Plymouth MN
International Classification:
A61B 1736
US Classification:
606 15
Abstract:
A technique for the treatment of ventricular tachycardia. The ventricles are endocardially mapped by way of an electrophysiological workup. This mapping locates the tachycardial foci and other abnormalities in conduction. A special catheter containing an optical fiber is percutaneously inserted into a blood vessel and advanced into the ventricle. The distal tip of the catheter is positioned adjacent to each of the tachycardia generating sites. A medical laser is used to irradiate each site via the optical fiber. The tissue at each site is thereby photocoagulated or ablated to remove the source of the tachyarythmia.
Catheter
US Patent:
5106386, Apr 21, 1992
Filed:
Nov 2, 1990
Appl. No.:
7/608290
Inventors:
Jeffrey M. Isner - Boston MA
Richard Clarke - Boston MA
Richard Clarke - Boston MA
Assignee:
AngeLase, Inc. - Plymouth MN
International Classification:
A61B 1736
US Classification:
606 15
Abstract:
A technique for percutaneous treatment of idiopathic hypertrophic subaortic stenosis (IHSS) and hypertrophic cardiomyopathy (HCM). IHSS and HCM are diseases of the heart in which the septum of the left ventricle thickens resulting in reduced ventricular performance. Current treatments involve drug therapy or a medical intervention called an interoperative myotomy/myectomy using the Morrow procedure. The present invention uses laser energy delivered via fiber optics placed percutaneously to irradiate the thickened septum to reduce tissue volume of the septum and enhance left ventricular function.
Catheter
US Patent:
4997431, Mar 5, 1991
Filed:
Aug 30, 1989
Appl. No.:
7/400702
Inventors:
Jeffrey M. Isner - Boston MA
Richard Clarke - Boston MA
Richard Clarke - Boston MA
Assignee:
Angeion Corporation - Plymouth MN
International Classification:
A61B 1736
US Classification:
606 15
Abstract:
A technique for percutaneous treatment of idiopathic hypertropic subaortic stenosis (IHSS) and hypertrophic cardiomyopathy (HCM). IHSS and HCM are diseases of the heart in which the septum of the left ventricle thickens resulting in reduced ventricular performance. Current treatments involve drug therapy or a medical intervention called an interoperative myotomy/myectomy using the Morrow procedure. The present invention uses laser energy delivered via fiber optics placed percutaneously to irradiate the thickened septum to reduce tissue volume of the septum and enhance left ventricular function.